• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    71 Biggest Movers From Yesterday

    4/27/22 4:27:24 AM ET
    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADXN alert in real time by email

    Gainers

    • Evoke Pharma, Inc. (NASDAQ:EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.
    • Nutex Health, Inc. (NASDAQ:NUTX) gained 73.8% to close at $7.68 on above-average volume despite no company-specific news.
    • Cyngn Inc. (NASDAQ:CYN) jumped 52.1% to close at $3.68 on above-average volume despite no company-specific news to justify the price action.
    • Forge Global Holdings, Inc. (NYSE:FRGE) gained 40.4% to close at $18.46 on above-average volume.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) jumped 29.8% to settle at $1.11. The U.S. Patent and Trademark Office issued Patent No. 11,311,612 covering GeoVax Labs modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) gained 27.3% to close at $1.68 after the company announced it entered into an equity acquisition agreement to acquire an automobile sales serviceshop operator under top china automaker Geely Auto's premium electronic vehicle brand Geometry.
    • Avadel Pharmaceuticals plc. (NASDAQ:AVDL) shares climbed 25.9% to close at $5.30 on Tuesday. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday morning that highlighted the company was not aware of any new information related to the company's FT218 New Drug Application that would have caused the stock to move.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) gained 23.8% to close at $5.35.
    • Arch Resources, Inc. (NYSE:ARCH) climbed 21% to close at $158.83 after the company reported better-than-expected Q1 sales results.
    • Lizhi Inc. (NASDAQ:LIZI) gained 20% to close at $1.32. LIZHI recently said it is collaborating with the in-car Xiaomi Quick App Platform to integrate LIZHI’s in-car audio product into Leapmotor vehicles’ operating system.
    • Q&K International Group Limited (NASDAQ:QK) shares climbed 18.6% to close at $1.18 after dropping around 5% on Monday.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 17.5% to close at $0.1119 after declining 4% on Monday.
    • Magnachip Semiconductor Corporation (NYSE:MX) shares climbed 16.5% to close at $17.51 following a Korea Economic Daily report titled "Korea's LX Group seeks to acquire Magnachip Semiconductor."
    • Cosmos Holdings Inc. (NASDAQ:COSM) jumped 16.5% to close at $1.06.
    • Eargo, Inc. (NASDAQ:EAR) surged 16.3% to settle at $4.07.
    • Mastech Digital, Inc. (NYSE:MHH) rose 15% to close at $20.99.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) jumped 14.3% to close at $40.80.
    • Travelzoo (NASDAQ:TZOO) gained 14.2% to close at $7.18 after the company reported better-than-expected Q1 EPS and sales results.
    • Sky Harbour Group Corporation (NYSE:SKYH) rose 13.9% to close at $10.58 after jumping 16% on Monday.
    • EuroDry Ltd. (NASDAQ:EDRY) gained 11.6% to settle at $35.96. EuroDry recently announced plans to acquire M/V Santa Cruz Bulker for $15.75 million.
    • The Sherwin-Williams Company (NYSE:SHW) climbed 9.4% to close at $271.37 after the company reported better-than-expected Q1 EPS and sales results.
    • Morphic Holding, Inc. (NASDAQ:MORF) rose 7% to close at $31.87.
    • PHX Minerals Inc. (NYSE:PHX) jumped 6.1% to close at $3.65.
    • Waste Management, Inc. (NYSE:WM) gained 5.3% to close at $164.15 after the company reported better-than-expected Q1 EPS and sales results.
    • Whirlpool Corporation (NYSE:WHR) jumped 4.6% to close at $187.16 after the company reported Q1 financial results and raised its buyback program by $2 billion.
    • Venator Materials PLC (NYSE:VNTR) rose 4.5% to close at $1.86 after the company announced the receipt of $85 million in cash from Tronox pursuant to its settlement agreement with Tronox.


    Losers

    • Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shares tumbled 50% to close at $9.41 on Tuesday after the company announced topline results from the Phase 2 IDEAL study of PN-943 in moderate-to-severe ulcerative colitis (UC) patients.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) declined 30% to close at $1.45 on above-average volume.
    • LogicBio Therapeutics, Inc. (NASDAQ:LOGC) fell 25.7% to close at $0.4010.
    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) dipped 23.8% to settle at $8.26 on below-average volume.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) shares fell 23.2% to settle at $1.29. Erytech Pharma shares jumped around 38% on Monday after the company announced it has sold its U.S. cell therapy manufacturing facility to Catalent For $44.5 million.
    • Winc, Inc. (NYSE:WBEV) fell 22.5% to close at $2.97.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) dropped 20.1% to close at $1.55.
    • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) fell 19.4% to settle at $1.12 on below-average volume.
    • Heidrick & Struggles International, Inc. (NASDAQ:HSII) dropped 19% to close at $32.11 following Q1 earnings.
    • Ventyx Biosciences, Inc. (NASDAQ:VTYX) fell 18.9% to close at $13.30.
    • Candel Therapeutics, Inc. (NASDAQ:CADL) fell 17.8% to close at $3.97.
    • Molecular Partners AG (NASDAQ:MOLN) fell 17.8% to close at $13.89. Molecular Partners said Emergency Use Authorization for Ensovibep, which is filed and in review with U.S. FDA, may require additional clinical data to be authorized.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) fell 17.7% to close at $3.30. Sunshine Biopharma recently reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 17.5% to close at $0.1119. Agile Therapeutics announced a 1-for-40 reverse stock split.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) dropped 17% to close at $0.6550.
    • Swvl Holdings Corp. (NASDAQ:SWVL) dipped 17% to close at $6.37.
    • NexImmune, Inc. (NASDAQ:NEXI) dipped 16.8% to close at $2.18. NexImmune reported a preclinical research collaboration with Columbia University Irving Medical Center's Herbert Irving Comprehensive Cancer Center.
    • Moving iMage Technologies, Inc. (NASDAQ:MITQ) dropped 16.7% to settle at $1.30. Moving iMage Technologies and SNDBX recently announced a strategic partnership to bring the full theatre experience to the gaming and e-Sports market.
    • Zymergen Inc. (NASDAQ:ZY) fell 16.6% to close at $1.71.
    • Inotiv, Inc. (NASDAQ:NOTV) dropped 16.4% to settle at $17.28. Inotiv recently announced acquisition of Histion.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) declined 16.3% to close at $0.4938.
    • Senmiao Technology Limited (NASDAQ:AIHS) fell 16.3% to close at $1.03.
    • Global Internet of People, Inc. (NASDAQ:SDH) dipped 16% to close at $1.68.
    • Leju Holdings Limited (NYSE:LEJU) fell 16% to close at $0.3611.
    • ION Geophysical Corporation (NYSE:IO) shares fell 15.7% to close at $0.58 after jumping 46% on Monday.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) dipped 15.5% to close at $7.67. Gossamer Bio recently announced topline results from the Phase 2 SHIFT-UC study in ulcerative colitis did not meet primary or secondary endpoints at week 12.
    • Longeveron Inc. (NASDAQ:LGVN) fell 15.5% to close at $10.41.
    • NuCana plc (NASDAQ:NCNA) fell 15.4% to close at $0.7177.
    • IM Cannabis Corp. (NASDAQ:IMCC) dipped 15.2% to settle at $1.12.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 15% to close at $1.93.
    • Cenntro Electric Group Limited (NASDAQ:CENN) fell 14.9% to close at $1.60 after reporting FY21 results.
    • ATIF Holdings Limited (NASDAQ:ATIF) dipped 14.8% to close at $2.82.
    • Nuvve Holding Corp. (NASDAQ:NVVE) declined 13% to close at $5.78. Nuvve Holding filed for mixed shelf of up to $100 million.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) fell 12.9% to close at $16.21. The company, last week, priced its IPO at $4 per share.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) dropped 12.9% to close at $3.10.
    • iHuman Inc. (NYSE:IH) fell 12.5% to settle at $2.59.
    • Tesla, Inc. (NASDAQ:TSLA) dipped 12.2% to close at $876.42.
    • General Electric Company (NYSE:GE) dipped 10.3% to close at $80.59 as the company reported first-quarter FY22 adjusted revenue of $16.3 billion flat year-over-year and organic revenues of $16.43 billion, up 1% Y/Y.
    • Nkarta, Inc. (NASDAQ:NKTX) dropped 10.3% to close at $16.79 as the company reported pricing of upsized public offering of common stock.
    • Universal Health Services, Inc. (NYSE:UHS) fell 9.7% to close at $125.32 after the company reported worse-than-expected Q1 EPS results.
    • TrueBlue, Inc. (NYSE:TBI) dipped 8.5% to close at $26.48 following Q1 results.
    • Polaris Inc. (NYSE:PII) fell 7.8% to settle at $98.49 after the company reported worse-than-expected Q1 EPS and sales results.
    • HSBC Holdings plc (NYSE:HSBC) fell 7.8% to close at $29.84 after the company reported a 28% drop in pre-tax profits for the first three months of 2022.
    • Helix Energy Solutions Group, Inc. (NYSE:HLX) fell 7.2% to close at $4.26 following Q1 results.
    • NextDecade Corporation (NASDAQ:NEXT) fell 6.6% to close at $5.66. Stifel downgraded NextDecade from Hold to Sell and raised the price target from $2 to $4.
    Get the next $ADXN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADXN
    $AGRX
    $AIHS
    $ARCH

    CompanyDatePrice TargetRatingAnalyst
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Gossamer Bio Inc.
    $GOSS
    1/28/2026$9.00Overweight
    Barclays
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    Sherwin-Williams Company
    $SHW
    1/23/2026$380.00Buy → Hold
    Deutsche Bank
    Waste Management Inc.
    $WM
    1/21/2026$250.00Sector Outperform → Sector Perform
    Scotiabank
    HSBC Holdings plc.
    $HSBC
    1/14/2026Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Helix Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information

    Helix Energy Solutions Group, Inc. (NYSE:HLX) will issue a press release reporting its fourth quarter and full year 2025 results on Monday, February 23, 2026, after the close of business. The press release and associated slide presentation will be available on Helix's website, www.helixesg.com. Helix will review its fourth quarter and full year 2025 results on Tuesday, February 24, 2026, at 9:00 a.m. Central Time via a teleconference and webcast. Investors and other interested parties wishing to participate should dial 1-800-715-9871 within the United States or 1-646-307-1963 outside the United States. The passcode is "Staffeldt." A live webcast of the teleconference will be available in

    2/6/26 4:15:00 PM ET
    $HLX
    Oilfield Services/Equipment
    Energy

    GE Aerospace Board of Directors Authorizes Quarterly Dividend

    CINCINNATI, Feb. 6, 2026 /PRNewswire/ -- The Board of Directors of GE Aerospace (NYSE:GE) today declared a $0.47 per share dividend on the outstanding common stock of the Company. The dividend is payable April 27, 2026, to shareholders of record at the close of business on March 9, 2026. The ex-dividend date is March 9, 2026. About GE Aerospace GE Aerospace (NYSE:GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 50,000 commercial and 30,000 military aircraft engines. With a global team of approximately 57,000 employees b

    2/6/26 1:34:00 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    POLARIS EXPANDS INDUSTRY'S LARGEST CABBED LINEUP WITH NEW RANGER MODELS FOR ALL‑SEASON COMFORT

    New 2026 RANGER 1000 CAB Improves Cold-Weather Comfort with Factory-Installed Heating System, New 2027 RANGER XP 1000 CAB Features HVAC System for All-Season Comfort at Competitive Price Point MINNEAPOLIS, Feb. 5, 2026 /PRNewswire/ -- Polaris Off Road, the world leader in powersports and off-road innovation, today announced two new enclosed cab models, the 2026 RANGER 1000 CAB and 2027 RANGER XP 1000 CAB. The new trim offerings expand the Polaris cabbed model portfolio and deliver versatile solutions at competitive price points. "Leveraging our expertise and adding to our brea

    2/5/26 12:31:00 PM ET
    $PII
    Industrial Specialties
    Consumer Discretionary

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Waddill William D. exercised 20,000 shares at a strike of $8.31 and sold $1,673,600 worth of shares (20,000 units at $83.68) (SEC Form 4)

    4 - Protagonist Therapeutics, Inc (0001377121) (Issuer)

    2/6/26 4:38:54 PM ET
    $PTGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Mccamish Mark Anthony gifted 67,025 units of Ordinary Shares and received a gift of 67,025 units of Ordinary Shares (SEC Form 4)

    4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)

    2/6/26 4:10:10 PM ET
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP; President - PeopleScout Betori Richard P. covered exercise/tax liability with 379 shares, decreasing direct ownership by 0.37% to 101,401 units (SEC Form 4)

    4 - TrueBlue, Inc. (0000768899) (Issuer)

    2/6/26 9:27:34 AM ET
    $TBI
    Professional Services
    Consumer Discretionary

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Shaw Steven A bought $34,013 worth of shares (4,880 units at $6.97) (SEC Form 4)

    4 - Mastech Digital, Inc. (0001437226) (Issuer)

    2/2/26 8:33:09 AM ET
    $MHH
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $175,000 worth of shares (353,321 units at $0.50), increasing direct ownership by 5% to 8,091,795 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/21/26 10:11:57 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    SEC Filings

    View All

    SEC Form 144 filed by Waste Management Inc.

    144 - WASTE MANAGEMENT INC (0000823768) (Subject)

    2/6/26 4:28:04 PM ET
    $WM
    Environmental Services
    Utilities

    Amendment: SEC Form SCHEDULE 13G/A filed by Ventyx Biosciences Inc.

    SCHEDULE 13G/A - Ventyx Biosciences, Inc. (0001851194) (Subject)

    2/6/26 4:13:53 PM ET
    $VTYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Protagonist Therapeutics Inc.

    SCHEDULE 13G/A - Protagonist Therapeutics, Inc (0001377121) (Subject)

    2/6/26 4:10:02 PM ET
    $PTGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CapitalOne initiated coverage on NextDecade with a new price target

    CapitalOne initiated coverage of NextDecade with a rating of Overweight and set a new price target of $7.00

    2/6/26 8:35:07 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Candel Therapeutics Inc.

    SC 13G - Candel Therapeutics, Inc. (0001841387) (Subject)

    12/17/24 12:30:40 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Ventyx Biosciences Inc.

    SC 13G/A - Ventyx Biosciences, Inc. (0001851194) (Subject)

    11/14/24 7:54:08 PM ET
    $VTYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Leadership Updates

    Live Leadership Updates

    View All

    Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer

    Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D

    1/20/26 8:00:00 AM ET
    $ACHC
    $UHS
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    Magnachip Announces the Appointment of Cristiano Amoruso to Its Board of Directors

    Magnachip Semiconductor Corporation (NYSE:MX) ("Magnachip" or the "Company") today announced the appointment of Cristiano Amoruso as an independent director, effective as of January 14, 2026, to its board of directors. "On behalf of the Board and management team, we are pleased to welcome Cristiano Amoruso as a director," said Camillo Martino, Chair of Magnachip's board of directors. "Having known him for more than 15 years, I have seen that Cristiano brings a rare combination of operational leadership and investment acumen in high-growth technology markets. His experience driving transformation and value creation will be highly valuable as we return the company to growth following our tr

    1/20/26 6:30:00 AM ET
    $MX
    Semiconductors
    Technology

    Magnachip Announces the Retirement of Director Ilbok Lee

    Magnachip Semiconductor Corporation (NYSE:MX) ("Magnachip" or the "Company") today announced that Ilbok Lee has notified the Company of his intention to retire from the Company's Board of Directors, to be effective at the Company's next scheduled Board meeting to be held on January 14, 2026. Dr. Lee joined Magnachip's Board in August 2011 and has served in multiple capacities for the Board during that time, including as Chair of the Nominating and Corporate Governance Committee, and as a member of the Board's Audit, Risk and Strategic Review Committees. During his tenure, Dr. Lee provided critical insight across a broad range of strategic, operational, and governance matters, and has been

    1/14/26 6:30:00 AM ET
    $MX
    Semiconductors
    Technology

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Financials

    Live finance-specific insights

    View All

    Helix Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information

    Helix Energy Solutions Group, Inc. (NYSE:HLX) will issue a press release reporting its fourth quarter and full year 2025 results on Monday, February 23, 2026, after the close of business. The press release and associated slide presentation will be available on Helix's website, www.helixesg.com. Helix will review its fourth quarter and full year 2025 results on Tuesday, February 24, 2026, at 9:00 a.m. Central Time via a teleconference and webcast. Investors and other interested parties wishing to participate should dial 1-800-715-9871 within the United States or 1-646-307-1963 outside the United States. The passcode is "Staffeldt." A live webcast of the teleconference will be available in

    2/6/26 4:15:00 PM ET
    $HLX
    Oilfield Services/Equipment
    Energy

    GE Aerospace Board of Directors Authorizes Quarterly Dividend

    CINCINNATI, Feb. 6, 2026 /PRNewswire/ -- The Board of Directors of GE Aerospace (NYSE:GE) today declared a $0.47 per share dividend on the outstanding common stock of the Company. The dividend is payable April 27, 2026, to shareholders of record at the close of business on March 9, 2026. The ex-dividend date is March 9, 2026. About GE Aerospace GE Aerospace (NYSE:GE) is a global aerospace propulsion, services, and systems leader with an installed base of approximately 50,000 commercial and 30,000 military aircraft engines. With a global team of approximately 57,000 employees b

    2/6/26 1:34:00 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

    WEST LAFAYETTE, Ind., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the "Company", or "Inotiv"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2026 first quarter ended December 31, 2025, on Monday, February 9, 2026, before the stock market opens. The Company will host a conference call that same day at 8:30 a.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialing: 1-800-445-7795 (Domestic)1-785-424-1699 (International)INOTIV (Co

    2/4/26 6:30:00 AM ET
    $NOTV
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care